The AgeTech Alliance
A Structured, Neutral Evaluation Framework for Aging Innovation
The AgeTech Alliance is Living Best’s structured engagement framework for organizations evaluating aging- and longevity-related opportunities. It provides neutral, decision-grade insight into which innovations, models, and approaches hold genuine relevance for Japan — and why.
The Alliance is designed for global ecosystem organizations such as foreign government innovation teams, venture investors, accelerators, academic institutions, healthcare systems, and AgeTech experts who seek structured access to Living Best’s evidence, methodology, and Japan-specific evaluation processes. Participation is open, free, and non-binding for organizations interested in engaging with the Alliance.
What Is the AgeTech Alliance?
The AgeTech Alliance offers organizations a structured way to interpret neutral evidence and align decision-making around validated priorities. It supports evaluation of:
● external innovations (shared by ecosystem partners or identified through global scanning)
● internal initiatives (R&D, service models, care pathways, investment themes, policy considerations)
● emerging opportunity areas informed by Japan’s system and demographic context
This framework is designed for organizations where aging-related decisions carry strategic, societal, or operational significance, and where clarity must be grounded in real-world evidence.
Alliance participation enables organizations to:
-
Interpret research insights and structured evidence relevant to aging and longevity
-
Align internal teams around shared, credible understanding of Japan’s real-world needs
-
Understand Japan relevance and readiness across system, care, cultural, and operational contexts
-
Reduce uncertainty before exploring pilots, collaborations, investment themes, or policy considerations
Why The Alliance Exists
Japan is the world’s earliest aging signal market. Understanding what works, why, and for whom requires evidence that integrates:
● lived experience from older adults and families
● expert interpretation from clinicians, researchers, policymakers, operators, and innovators
● contextual alignment across Japan’s care, system, operational, and cultural environment
● global signals shaping the evolution of aging innovation
Living Best delivers this integration through the Market Performance Indicator (MPI), our neutral, multi-stakeholder evaluation process built specifically for Japan.
Shared Multi-Stakeholder Evidence
The AgeTech Alliance integrates structured insight from older adults and families, domain experts, policymakers, care operators, innovators, and global ecosystem contributors. This multi-stakeholder approach strengthens the quality and relevance of the evidence generated through the Market Performance Indicator (MPI).
● Lived-experience insight from older adults, carers, and families
● Expert and practitioner interpretation
● Policy and system perspectives from Japan’s aging environment
● Operational, organizational, and feasibility considerations
● Global readiness and maturity signals from international innovation pipelines
This evidence helps organizations clarify what works, why, and for whom in Japan – and where risks or misalignments may limit success.
Strategic Alignment & Prioritisation
The Alliance supports clarity and shared understanding by helping organizations:
● Identify opportunities with genuine relevance to Japan
● Reduce ambiguity early in decision-making
● Strengthen cross-functional interpretation of evidence
● Understand risks before exploring pilots, collaborations, or investment themes
This supports more confident, evidence-based decisions across innovation, policy, research, and investment contexts.
Structured Insight into Global AgeTech
The Alliance provides a neutral framework for interpreting global AgeTech trends, emerging commercial models, and international innovation signals through the lens of Japan’s real-world needs.
● Mapping global innovation patterns to Japan’s demographic and system context
● Identifying high-potential themes emerging internationally
● Understanding maturity, readiness, and risks across different markets
● Clarifying where global insights can inform Japan-relevant decision-making
This approach helps organizations engage globally without exposure to noise, hype, or misaligned solutions.
For Ecosystem Partners
HOW GLOBAL ORGANIZATIONS CAN ENGAGE WITH THE ALLIANCE
Global ecosystem organizations are invited to contribute to MPI’s evidence base. Organizations engaging with the Alliance can do so by: sharing promising innovations for structured evaluation, contributing expert perspectives to multi-stakeholder reviews, participating in selected insight and research activities, and supporting evidence-led interpretation of global AgeTech trends. Participation is free and non-binding. These contributions help ensure MPI findings reflect diverse, real-world perspectives and support better decisions across Japan’s aging innovation landscape.
What Organisations Gain
The AgeTech Alliance provides organizations with:
● a neutral framework to evaluate innovations and opportunity areas
● interpreted insight into Japan’s user, system, care, and cultural context
● high-level synthesis of global and domestic AgeTech signals
● a structured way to explore Japan relevance before committing resources
● responsible, evidence-led visibility for high-potential innovations
● connection to a global community shaping aging innovation
This creates a responsible, credible foundation for decision-making – across innovation, investment, policy, and research.
At the Centre: The Market Performance Indicator (MPI)
MPI is Living Best’s neutral, structured, multi-stakeholder evaluation framework.
MPI synthesises evidence from:
✅ User Group – older adults, carers, and families across Japan
✅ Professional Group – researchers, clinicians, policymakers, operators, innovators
✅ Ecosystem Contributors – global innovators, government agencies, academic institutions, healthcare systems, and venture investors.
MPI clarifies:
● what works, why, and for whom
● which innovations show relevance for Japan
● which approaches are unlikely to succeed
● how global trends map to Japan’s unique needs
Engage With the AgeTech Alliance
If your organization is exploring pathways into Japan or would like to engage with the Alliance, we welcome a conversation. Participation is free and designed to support evidence-led collaboration between global innovators and Japan’s ageing society.
Please submit your details below. A member of our team will follow up to understand your objectives and discuss how the Alliance can support your work.